In Janssen Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc., Appeal No. 25-1228, The Federal Circuit found that claims reciting a dosing regimen with unequal loading doses were not obvious and that a presumption of...more
Distribution Agreements Can Constitute Offers for Sale Under Section 102(b) -
In The Medicines Company v. Hospira, Inc., Appeal Nos. 2014-1469, 2014-1504, the Federal Circuit held that a distribution agreement qualified as...more
4/11/2018
/ Amended Complaints ,
Appeals ,
Broadest Reasonable Interpretation Standard ,
Claim Construction ,
Computer-Related Inventions ,
Direct Infringement ,
Federal Rule 12(b)(6) ,
Generic Drugs ,
Indefiniteness ,
Inter Partes Review (IPR) Proceeding ,
Motion to Dismiss ,
Obviousness ,
On-Sale Bar ,
Patent Invalidity ,
Patent-Eligible Subject Matter ,
Patents ,
Pharmaceutical Patents ,
Pleading Standards ,
Prior Art ,
Question of Fact ,
Question of Law ,
Remand ,
Reversal ,
Sales & Distribution Agreements ,
Section 101 ,
Standard of Review ,
Summary Judgment
Federal Circuit Holds That Using A Contract Manufacturer Does Not Trigger An On-Sale Bar -
In The Medicines Co. v. Hospira, Inc., Appeal Nos. 2014-1469, -1504, the Federal Circuit, en banc, held that the patentee’s deal...more
9/6/2016
/ Appeals ,
Claim Construction ,
Foreign Corporations ,
Indefiniteness ,
Long Arm Statute ,
Means-Plus-Function ,
Minimum Contacts ,
Noninfringement ,
On-Sale Bar ,
Patent Litigation ,
Patents ,
Personal Jurisdiction ,
Reversal ,
Sales & Distribution Agreements ,
Summary Judgment